• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    AdvanSix Appoints Gena C. Lovett to Board of Directors

    9/10/21 6:45:00 AM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email

    AdvanSix (NYSE:ASIX) announced today the appointment of Gena C. Lovett as a new independent member of its Board of Directors. Ms. Lovett most recently served as Vice President of Manufacturing, Safety and Quality for The Boeing Company's Defense, Space & Security division, a $30 billion organization. Ms. Lovett will serve on the Nominating and Governance Committee and the Health, Safety, Environmental and Sustainability Committee of the Board of Directors. AdvanSix's Board now consists of nine members, including eight independent directors.

    "We are very excited to welcome Gena to the AdvanSix Board and leverage her insight and unique skill set to advance our corporate strategic priorities," said Michael Marberry, Board Chairman of AdvanSix. "Gena brings decades of strategic leadership experience with an extensive background in manufacturing and operations and we look forward to her contributions."

    Prior to her joining The Boeing Company in 2015, Ms. Lovett served in multiple roles at Alcoa Corporation including as Chief Diversity Officer and Director of Manufacturing, Forgings. From 1992 to 2007, Ms. Lovett held a series of manufacturing positions of increasing responsibility at Ford Motor Company, moving up from Production Supervisor to Plant Manager. Ms. Lovett received her B.A. from The Ohio State University, her M.B.A. from the Baker College Center for Graduate Studies and her M.S. in Values Driven Leadership from Benedictine University. She is currently pursuing her Ph.D. in Values Driven Leadership at Benedictine University and was recently named to the Board of Directors of Trex Company, Inc.

    "Gena will be a valuable addition to our Board and we look forward to benefitting from her perspective and wealth of leadership expertise in both manufacturing and diversity efforts within global organizations. Her perspective can help us significantly as we drive the company forward to achieve sustainable value for all our stakeholders," said Erin Kane, president and CEO of AdvanSix.

    About AdvanSix

    AdvanSix plays a critical role in global supply chains, innovating and delivering essential products for our customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, plastics, solvents, packaging, paints, coatings, adhesives and electronics. Our reliable and sustainable supply of quality products emerges from the vertically integrated value chain of our three U.S.-based manufacturing facilities. AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, chemical intermediates, and plant nutrients, guided by our core values of Safety, Integrity, Accountability and Respect. More information on AdvanSix can be found at http://www.advansix.com.

    Forward Looking Statements

    This release contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," "outlook," "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally, including the impact of the coronavirus (COVID-19) pandemic and any resurgences; the scope, duration and pace of recovery of the pandemic; the timing of the distribution and efficacy of vaccines or treatments for COVID-19 that are currently available or may be available in the future and related vaccination rates; the severity and transmissibility of newly identified strains of COVID-19; governmental, business and individuals' actions in response to the pandemic, including our business continuity and cash optimization plans that have been, and may in the future be, implemented; the impact of social and economic restrictions and other containment measures taken to combat virus transmission; the effect on our customers' demand for our products and our suppliers' ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services, including as a result of travel and other COVID-19-related restrictions; the ability of our customers to pay for our products; any closures of our and our customers' offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks and disruptions to our technology infrastructure; risks associated with employees working remotely or operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost or at all due to economic conditions resulting from COVID-19 or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters and pandemics; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; cybersecurity, data privacy incidents and disruptions to our technology infrastructure; failure to maintain effective internal controls; disruptions in transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020, as updated in subsequent reports filed with the SEC.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210910005117/en/

    Get the next $ASIX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Roberts Daryl claimed no ownership of stock in the company (SEC Form 3)

    3 - AdvanSix Inc. (0001673985) (Issuer)

    9/8/25 5:23:30 PM ET
    $ASIX
    Major Chemicals
    Industrials

    New insider O'Brien Dana C. claimed no ownership of stock in the company (SEC Form 3)

    3 - AdvanSix Inc. (0001673985) (Issuer)

    9/8/25 5:18:08 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SVP, General Counsel Kintiroglou Achilles B. sold $12,105 worth of shares (571 units at $21.20), decreasing direct ownership by 2% to 30,842 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    9/3/25 4:31:01 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Dana O'Brien and Daryl Roberts as new independent members of its Board of Directors. Ms. O'Brien recently retired as Senior Vice President and Chief Legal Officer of Olin Corporation, a leading vertically integrated global manufacturer and distributor of chemical products. Ms. O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee of the Board. Mr. Roberts is currently Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc., a global innovation leader with technology-based materials and solutions t

    9/2/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Announces Second Quarter 2025 Financial Results

    2Q25 Sales of $410 million, down 10% versus prior year 2Q25 Earnings Per Share of $1.15; Adjusted Earnings Per Share of $1.24 2Q25 Cash Flow from Operations of $21 million $8 million of 45Q carbon capture tax credits claimed in 2Q25 AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the second quarter ending June 30, 2025. Overall, the Company delivered resilient earnings with strong sequential improvement and executed key growth and enterprise initiatives to support long-term sustainable performance. Second Quarter 2025 Summary "Our resilient second quarter results reflect our collective organization's execution and the advantages of

    8/1/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Second Quarter Financial Results and Hold Investor Conference Call on August 1

    AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its second quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, August 1. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's second quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on August 1 until 12 noon ET on August 8. You can listen to the replay by dialing (87

    7/11/25 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    SEC Filings

    View All

    AdvanSix Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AdvanSix Inc. (0001673985) (Filer)

    9/2/25 4:21:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form 144 filed by AdvanSix Inc.

    144 - AdvanSix Inc. (0001673985) (Subject)

    8/1/25 5:16:01 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by AdvanSix Inc.

    10-Q - AdvanSix Inc. (0001673985) (Filer)

    8/1/25 4:10:40 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    11/19/24 4:20:20 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AdvanSix upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

    5/19/25 8:45:52 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

    4/7/25 8:48:39 AM ET
    $ASIX
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on AdvanSix with a new price target

    Piper Sandler initiated coverage of AdvanSix with a rating of Overweight and set a new price target of $58.00

    11/12/21 4:57:29 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    View All

    AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Dana O'Brien and Daryl Roberts as new independent members of its Board of Directors. Ms. O'Brien recently retired as Senior Vice President and Chief Legal Officer of Olin Corporation, a leading vertically integrated global manufacturer and distributor of chemical products. Ms. O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee of the Board. Mr. Roberts is currently Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc., a global innovation leader with technology-based materials and solutions t

    9/2/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Appoints Sidd Manjeshwar as Senior Vice President and Chief Financial Officer

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Sidd Manjeshwar as Senior Vice President and Chief Financial Officer, effective October 1st. In this role, Mr. Manjeshwar will have global responsibility for controllership, treasury, investor relations, procurement, internal audit, commercial finance, tax and financial planning and analysis for the enterprise. Mr. Manjeshwar will report directly to Erin Kane, President and CEO of AdvanSix, and be a member of the Company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911629335/en/Sidd Manjeshwar, incoming SVP

    9/12/24 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Appoints Donald P. Newman to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Donald P. Newman as a new independent member of its Board of Directors. Mr. Newman is currently Executive Vice President, Finance and Chief Financial Officer of ATI Inc., a global producer of high-performance materials and solutions for the global aerospace and defense markets and critical applications in electronics, medical and specialty energy. Mr. Newman will serve on the Audit Committee and the Health, Safety and Environmental Committee of the Board of Directors. AdvanSix's Board now consists of nine members, including eight independent directors. "Don is well recognized for his financial expert

    8/19/24 4:30:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Financials

    Live finance-specific insights

    View All

    AdvanSix Announces Second Quarter 2025 Financial Results

    2Q25 Sales of $410 million, down 10% versus prior year 2Q25 Earnings Per Share of $1.15; Adjusted Earnings Per Share of $1.24 2Q25 Cash Flow from Operations of $21 million $8 million of 45Q carbon capture tax credits claimed in 2Q25 AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the second quarter ending June 30, 2025. Overall, the Company delivered resilient earnings with strong sequential improvement and executed key growth and enterprise initiatives to support long-term sustainable performance. Second Quarter 2025 Summary "Our resilient second quarter results reflect our collective organization's execution and the advantages of

    8/1/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Second Quarter Financial Results and Hold Investor Conference Call on August 1

    AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its second quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, August 1. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's second quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on August 1 until 12 noon ET on August 8. You can listen to the replay by dialing (87

    7/11/25 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Announces First Quarter 2025 Financial Results

    1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

    5/2/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/13/24 4:55:58 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/9/24 9:58:57 AM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by AdvanSix Inc.

    SC 13G - AdvanSix Inc. (0001673985) (Subject)

    2/7/24 8:39:58 AM ET
    $ASIX
    Major Chemicals
    Industrials